DroxyDopa is a pharmaceutical active pharmaceutical ingredient (API) and a synthetic amino-acid derivative developed as a precursor to norepinephrine. It is associated with pharmacological applications involving the regulation of blood pressure and is used in specialized pharmaceutical formulations.
DroxyDopa is a synthetic precursor that can be converted enzymatically to norepinephrine. It is designed to increase norepinephrine availability and thereby support blood-pressure regulation in appropriate clinical settings.
DroxyDopa is a small-molecule pharmaceutical ingredient used in the development and manufacture of specialized formulations. Its pharmacological activity is related to its conversion into norepinephrine, an important neurotransmitter involved in vascular tone and blood-pressure regulation.
DroxyDopa is converted to norepinephrine by the enzyme aromatic L-amino acid decarboxylase. Increased norepinephrine availability can enhance vascular tone and contribute to an increase in blood pressure.
DroxyDopa has been investigated and used in pharmaceutical applications related to:
The exact indication depends on the approved pharmaceutical formulation and applicable regulatory labeling.
DroxyDopa is a synthetic amino-acid derivative. It is generally handled as a pharmaceutical-grade crystalline solid and has physicochemical characteristics associated with its amino-acid structure.
DroxyDopa API intended for pharmaceutical manufacturing should be produced under appropriate GMP controls and tested according to applicable quality and regulatory requirements. Quality evaluation may include identity, assay, related substances, water content, residual solvents, elemental impurities and other relevant quality attributes.
DroxyDopa is a specialized pharmaceutical ingredient for formulations associated with blood-pressure regulation. Pharmaceutical manufacturers and formulation developers can evaluate the material based on applicable regulatory requirements, analytical documentation, quality specifications and batch-specific Certificate of Analysis.
| Parameter | Specification |
|---|---|
| Appearance | White to off-white crystalline powder |
| Identification | IR & HPLC compliant |
| Assay (HPLC) | 98.0% – 102.0% |
| Loss on Drying | NMT 1.0% |
| Residue on Ignition | NMT 0.5% |
| Heavy Metals | NMT 20 ppm |
| pH (1% Solution) | 2.0 – 4.0 |
| Individual Impurity | NMT 0.5% |
| Total Impurities | NMT 1.0% |
| Water Content | NMT 1.0% |